Literature DB >> 6973576

Induction of human immunoglobulin secretion. I. Synergistic effect of B cell mitogen Cowan I plus T cell mitogens or factors.

O Saiki, P Ralph.   

Abstract

Synergistic effects of B cell mitogen Staphylococcus bacteria strain Cowan I (Cowan I) plus T cell mitogens in generating immunoglobulin-secreting cells (ISC) from human peripheral blood mononuclear cells (MNC) were investigated. ISC were assayed by reverse plaque-forming cells with protein A-coated red blood cells. Low concentrations of pokeweed mitogen (PWM) plus Cowan I gave superadditive effects on ISC induction, generating 3 to 10 times as many ISC as optimal amounts of either mitogen alone. The mitogens together and separately showed similar kinetics of ISC; synergy was observed at every day tested. Plaque-forming cells of IgM, IgG, and IgA classes all showed strong synergy, together routinely representing 20% of initial MNC. At day 7 of culture, over 80% of non-E-rosetting cells were ISC. Cell donors tested gave these strong responses even if they were low responders to either mitogen alone. Cowan I plus other T cell mitogens, PHA, Con A, and protein A, also provided good signals for B cell activation. Cowan I induced marked proliferation of purified B cells, but T cell-helper signals were required for differentiation to ISC. T cell-helper factor, induced by PWM or PHA, also showed synergistic effects with Cowan I in induction of ISC. Purified B cells did not respond to T cell-helper factor(s) alone to proliferate or differentiate to ISC. These results indicate that optimal ISC induction occurs with a B cell mitogen plus T cell signals acting synergistically.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973576

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  Human B lymphocytes mature.

Authors:  J Gordon
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

2.  Delineation of the functional capacity of human neonatal lymphocytes.

Authors:  J B Splawski; D F Jelinek; P E Lipsky
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

3.  Role of B cells in common variable immune deficiency.

Authors:  Sam Ahn; Charlotte Cunningham-Rundles
Journal:  Expert Rev Clin Immunol       Date:  2009-09       Impact factor: 4.473

4.  Polyclonal antibody formation of human lymphocytes to bacterial components.

Authors:  L Räsänen; M Lehto; I Jokinen; P Leinikki
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

5.  IgA specific helper factor (alpha HF) in human colostrum.

Authors:  H Shinmoto; H Kawakami; S Dosako; Y Sogo
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

6.  The B-cell activation pathway in human systemic lupus erythematosus: imbalanced in vitro production of lymphokines and association with serum analytical findings.

Authors:  M L Gaspar; M Alvarez-Mon; C Gutierrez
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

Review 7.  Administration of recombinant IL-2 augments the level of serum IgM in an IL-2 deficient patient.

Authors:  S Doi; O Saiki; T Hara; T Sugita; K Ha-Kawa; T Tanaka; H Hara; S Negoro; H Yabuuchi; S Kishimoto
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

8.  Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency.

Authors:  G Kruger; K Welte; N Ciobanu; C Cunningham-Rundles; P Ralph; S Venuta; S Feldman; B Koziner; C Y Wang; M A Moore
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

9.  Paracoccidioides brasiliensis-stimulated human gamma/delta T cells support antibody production by B cells.

Authors:  M E Munk; R A Fazioli; V L Calich; S H Kaufmann
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Mitogenic stimulation of malignant B cells. Chronic lymphocytic leukaemia: relationship between stimulation and surface phenotype.

Authors:  A C Bloem; E J Bast; F H Gmelig Meyling; G C DeGast; R E Ballieux
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.